BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Menyailo ME, Tretyakova MS, Denisov EV. Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds. Int J Mol Sci 2020;21:E1696. [PMID: 32121639 DOI: 10.3390/ijms21051696] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Rossi T, Gallerani G, Angeli D, Cocchi C, Bandini E, Fici P, Gaudio M, Martinelli G, Rocca A, Maltoni R, Fabbri F. Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer. Cancers (Basel) 2020;12:E2490. [PMID: 32887501 DOI: 10.3390/cancers12092490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
2 Mohan A, Raj R R, Mohan G, K P P, Thomas Maliekal T. Reporters of Cancer Stem Cells as a Tool for Drug Discovery. Front Oncol 2021;11:669250. [PMID: 33968778 DOI: 10.3389/fonc.2021.669250] [Reference Citation Analysis]
3 Ma B, Ran R, Liao HY, Zhang HH. The paradoxical role of matrix metalloproteinase-11 in cancer. Biomed Pharmacother 2021;141:111899. [PMID: 34346316 DOI: 10.1016/j.biopha.2021.111899] [Reference Citation Analysis]
4 Menyailo ME, Bokova UA, Ivanyuk EE, Khozyainova AA, Denisov EV. Metastasis Prevention: Focus on Metastatic Circulating Tumor Cells. Mol Diagn Ther 2021;25:549-62. [PMID: 34287797 DOI: 10.1007/s40291-021-00543-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Şener BB, Yiğit D, Bayraç AT, Bayraç C. Inhibition of cell migration and invasion by ICAM-1 binding DNA aptamers. Anal Biochem 2021;628:114262. [PMID: 34038704 DOI: 10.1016/j.ab.2021.114262] [Reference Citation Analysis]
6 Ramos-Medina R, López-Tarruella S, Del Monte-Millán M, Massarrah T, Martín M. Technical Challenges for CTC Implementation in Breast Cancer. Cancers (Basel) 2021;13:4619. [PMID: 34572846 DOI: 10.3390/cancers13184619] [Reference Citation Analysis]
7 Cai D, Li N, Jin L, Qi X, Hua D, Wang T. High CTC-TRPC5 Expression Significantly Associated With Poor Prognosis in Radical Resected Colorectal Cancer Patients. Front Mol Biosci 2021;8:727864. [PMID: 34422911 DOI: 10.3389/fmolb.2021.727864] [Reference Citation Analysis]
8 Rossi T, Gallerani G, Martinelli G, Maltoni R, Fabbri F. Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue. Biomedicines 2021;9:1242. [PMID: 34572427 DOI: 10.3390/biomedicines9091242] [Reference Citation Analysis]
9 Genna A, Vanwynsberghe AM, Villard AV, Pottier C, Ancel J, Polette M, Gilles C. EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis. Cancers (Basel) 2020;12:E1632. [PMID: 32575608 DOI: 10.3390/cancers12061632] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
10 Lee JS, Kim HY, Won B, Kang SW, Kim YN, Jang H. SEZ6L2 Is an Important Regulator of Drug-Resistant Cells and Tumor Spheroid Cells in Lung Adenocarcinoma. Biomedicines 2020;8:E500. [PMID: 33202873 DOI: 10.3390/biomedicines8110500] [Reference Citation Analysis]